SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (243)5/2/2001 5:28:57 PM
From: Jim Oravetz  Read Replies (1) of 370
 
NEW HAVEN — Vion Pharmaceuticals saw its first quarter losses increase as the company continued its efforts to develop cancer drugs.

First quarter losses at the New Haven-based biotechnology company were $3.7 million or 14 cents per share, a 19 percent increase over the same period a year earlier. The company lost $3.1 million or 16 cents per share. The two-cent per share decreases in losses this year is the result of Vion having 6.4 million shares outstanding during the first quarter of this year. Operating expenses at Vion also increased. The company spent $4.3 million in operating expenses during the first quarter of this year, up $1.3 million from the same period a year earlier. Company officials said operating expenses escalated as Vion expanded clinical trials of its drug candidates. "We have been able to effectively manage our funds in the first quarter of 2001, with cash reserves sufficient to complete already scheduled Phase I and Phase II clinical trials," said Alan Kessman, Vion’s president and chief executive officer. Vion’s shares trade on the Nasdaq Stock Market under the symbol VION. The company’s stock rose four cents on Monday to close at $3.95.

From New Haven Register paper
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News